Pharma Serialization: First Experience, Best Practices, Future Direction

James D. Chambers, PhD, MPharm, MSc, professor of medicine at the Tufts Medical Center Institute for Clinical Research and Health Policy Studies, dives into why biosimilars contribute to a reduction in cost and increase in patient access, while highlighting challenges to adoption.

Donald Prentiss discusses the value of these pharmacies, especially during shortages.

The timing for the potential tax is yet to be determined, as the industry awaits to see the impact it could bring.

Nicholas Saraceno offers an overview of the legislation and how it impacts the pharma supply chain.

The facilities are expected to offer pharma shipment support by addressing time and temperature-specific requirements.

Trade & Channel Strategies conference explores the frontline issues related to strategy, distribution, and reimbursement—while digging into creative solutions to solve them.